Litcius/Paper detail

Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy

Helen Clare Dearden, Lewis Au, Daniel Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Cuvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies

2021European Journal of Cancer30 citationsDOI

Topics & Concepts

MedicineIpilimumabImmunosuppressionToxicityInternal medicineNivolumabGastroenterologyPneumonitisRashImmunotherapyCancerLungCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways
Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy | Litcius